Market Data 
Markets
Replies to post #133271 on Biotech Values
12/22/11 1:54 PM
Under the agreement, Bristol-Myers Squibb will fund Gladstone’s research efforts to identify targets that affect Tau dysfunction. Tau is a protein that binds the cell’s internal skeleton and may help regulate the activity of brain cells. In Alzheimer’s disease, Tau forms abnormal deposits called neurofibrillary tangles, a hallmark pathology of the disease. By identifying targets that prevent or reverse Tau dysfunction, Bristol-Myers Squibb and Gladstone hope to identify novel therapeutic strategies to modify the course of the disease.
AI
